首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1477279

個人化醫療市場，依應用、依適應症、依最終用戶、依地理位置

Personalized Medicine Market, By Application, By Indication, By End User, By Geography

出版日期: 2024年03月28日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球個人化醫療市場價值為813.3億美元，預計到2031年將達到1524億美元，2024年至2031年年複合成長率（CAGR）為9.4%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	813.3 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	9.40%	2031 年價值預測：	1,524 億美元

圖 1. 2024 年個人化醫療市場佔有率 (%)（依地區）

個人化醫療旨在根據每位患者的個別特徵量身定做醫療保健，根據遺傳學、生物標記和臨床風險因素提供有針對性的治療。它代表了從一刀切的治療和疾病預防方法到考慮患者基因、環境和生活方式的個體差異的高度客製化系統的演變。個人化醫療有可能透過更明智的醫療決策來減少藥物不良反應、提高治療效果並改善健康結果。隨著基因檢測、巨量資料分析和分子診斷的進步，醫生能夠從基因上分析患者對特定疾病的易感性，並相應地最佳化治療。這個新興領域正在改變個人層面上疾病的診斷、治療和預防方式。

市場動態：

個人化醫療市場的推動因素包括製藥公司的醫療保健成本和藥物開發成本不斷上升、對標靶治療的需求不斷增加、伴隨診斷的日益突出、對精準醫療的日益關注以及用於研究的遺傳資料的可用性。然而，患者和醫生缺乏對這種方法的認知、高昂的前期成本以及監管問題阻礙了該市場的成長。發展新興經濟體的醫療基礎設施為市場參與者提供了巨大的成長機會。市場領導者正在投資巨量資料分析，並與診斷測試公司合作開發組合產品，以改善患者的治療效果。藥物基因組學和伴隨診斷的持續研究將在未來十年進一步擴大個人化醫療的能力。

研究的主要特點：

該報告對全球個人化醫療市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球個人化醫療市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球個人化醫療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球個人化醫療市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

第 10 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6807

The global personalized medicine market is estimated to be valued at USD 81.33 Bn in 2024 and is expected to reach USD 152.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 81.33 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	9.40%	2031 Value Projection:	US$ 152.4 Bn

Figure 1.Personalized Medicine Market Share (%), By Region, 2024

Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a one-size-fits-all approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.

Market Dynamics:

The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.

Key Features of the Study:

This report provides an in-depth analysis of the global personalized medicine market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market

Detailed Segmentation-

Application:
- Therapeutics
- Nutrition & Wellness
- Diagnostics
- Others
Indication:
- Oncology
- Immunology
- Neurology
- Cardiology
- Autoimmune Diseases
- Others
End User:
- Hospital & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Personalized Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Personalized Medicine Market, By Application, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Nutrition & Wellness
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Personalized Medicine Market, By Indication, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Personalized Medicine Market, By End User, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Personalized Medicine Market, By Region, 2019 - 2031, (USD BN)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Precision Biologics*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D